Anthony Magliocco, MD, Founder & CEO of Protean BioDiagnostics, will discuss the impact of the precision oncology revolution on the practice of pathology and laboratory medicine.
Objectives of This Webinar:
Understand the impact of the precision oncology revolution on the practice of pathology and laboratory medicine
Review new technologies that will shape the future of laboratory medicine, including digital pathology, multi-omics, liquid biopsy and more
Discuss the data challenges and opportunities of integrating machine learning into pathology practice
Identify the major barriers to adoption and transformation of pathology
Listen to recording of webinar: https://register.gotowebinar.com#register/8637373438261374732